Publicaciones en colaboración con investigadores/as de Washington University in St. Louis School of Medicine (1)

2022

  1. Long-term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow-up

    HemaSphere